November 2017

November 2017

Welcome to the November issue of The Ophthalmologist! Upfront’s topics include a new 24-hour IOP monitor and incidences of PCO with different IOL materials. In My View sees Juan Carlos-Serna discuss what ophthalmologists can do when disaster strikes, Roy Rubinfeld says it is time to drop the epi-on crosslinking debate, and João Barbosa-Breda focuses on how metabolomics will shape the future of glaucoma care. In our Feature, Javier Zarranz-Ventura, David Johnston and Adnan Tufail pay homage to Robert Johnston – one of ophthalmology’s true figure heads who shaped the practice as we know it today. NextGen sees Peter Kaiser overview drug delivery devices for neovascular disease, and in Profession, Robert Osher talks about setting up a successful cataract meeting and C. Andrès Benatti tackles the dogma of ‘brain drain’. Finally, we Sit Down With Cynthia Matossian, Founder and Medical Director of Matossian Eye Associates.